๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Estimation of Multiple Response Rates in Phase II Clinical Trials with Missing Observations

โœ Scribed by Chang, Myron

Book ID
111647367
Publisher
Taylor and Francis Group
Year
2009
Tongue
English
Weight
112 KB
Volume
19
Category
Article
ISSN
1054-3406

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II trial of amsacrine in patients
Phase II trial of amsacrine in patients with multiple myeloma
โœ Greipp, Philip R. ;Coleman, Morton ;Anderson, Keaven ;McIntyre, O. Ross ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 239 KB

Seventy-four previously treated patients with multiple myeloma were treated with Amsacrine (m-AMSA) 120 mg/m2 every 3 weeks. A good response was observed in two patients (3%), and improvement was seen in three patients (4%). Severe toxicity was observed in 33% of patients who received three or more

The conduct of phase I-II clinical trial
The conduct of phase I-II clinical trials in children with cancer
โœ Pratt, Charles B. ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 677 KB

Phase I Clinical Trials in children with cancer are carried out with therapeutic intent, so as to define antileukemic/antitumor activity, dose-limiting toxicity, maximum tolerated dosage, and pharmacokinetics. These studies define a dosage of an agent or combination that may be used in a larger stud